Brain cells critical for mouse navigation found to be highly specialised
11 June 2026
Researchers from the Department of Pharmacology have found that the ‘neural compass’ that enables mice to navigate is formed of specialised brain cells that respond in different ways to stimuli such as light and sound.
First trial of vaccine to prevent Lynch syndrome-associated cancers approved to start in Oxford
9 June 2026
Phase 1 of the INTERCEPT-Lynch trial, which is funded by Moderna, sponsored by the University of Oxford and run by the University's Oncology Clinical Trials Office with support from Oxford Cancer, has received authorisation from the Medicines and Healthcare products Regulatory Agency and is expected to begin recruiting participants this summer.
Oxford joins major new Educational Neuroscience centre to shape government policy
8 June 2026
Professor Gaia Scerif from the Department of Experimental Psychology is a key partner in a newly announced research centre that will help shape education policy across England.
Exosomes are more diverse than we previously thought: implications for disease diagnosis and management
5 June 2026
A new opinion article published in Trends in Cell Biology explores how tiny packages released by cells, known as exosomes, could help researchers better understand disease and may one day support new approaches to diagnosis and treatment.
Pioneering study sets out to answer and address why osteoarthritis impacts patients differently
3 June 2026
Researchers from the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) are playing leading roles in a major new UK-wide research consortium aiming to improve treatment and outcomes for people living with osteoarthritis.
New type of inhibitor could help tackle resistance against ‘last-resort’ antibiotics
3 June 2026
Researchers from the Ineos Oxford Institute for antimicrobial research (IOI) have identified a new class of molecule that could help protect ‘last-resort’ antibiotics from bacterial resistance, and reduce the amount of antibiotics needed to treat infections by up to 32 times.
Largest study of knee osteoarthritis tissue reveals the core biological pathways underlying osteoarthritis
2 June 2026
A major international study led by researchers at the Kennedy Institute of Rheumatology at the University of Oxford has found that osteoarthritis (OA) – the most common form of arthritis worldwide – is not a collection of separate diseases, as many scientists had previously speculated, but rather a single condition with common core underlying biological pathways.
New study shows the brain uses brief, slow rhythms to organise how memories are formed, stored, and later recalled
1 June 2026
A new study from the University of Oxford and le Centre National de la Recherche Scientifique (CNRS) has shown that the brain uses rhythms for brain cell impulses to coordinate activity across memory-related regions in the brain during learning and help reactivate those experiences afterwards, strengthening what we remember.
Oxford Bundibugyo ebolavirus vaccine candidate receives CEPI backing
1 June 2026
The Coalition for Epidemic Preparedness Innovations (CEPI) has announced today that it will urgently accelerate the development of three investigational vaccines targeting the Bundibugyo ebolavirus that has caused a rapidly spreading epidemic in the Democratic Republic of the Congo (DRC) and neighbouring Uganda, including one being developed by the Oxford Vaccine Group at the University of Oxford.
UK and France launch landmark biomedical and AI health alliance to accelerate research into major diseases
29 May 2026
A new partnership will unite expertise, infrastructure and data across borders to accelerate diagnosis, treatment and ultimately prevention of major diseases – starting with women’s health, infectious diseases and pandemic preparedness.
University of Oxford launches new public awareness campaign for Neurodevelopmental Disorders
28 May 2026
The Department of Paediatrics at the University of Oxford today announces the launch of Genes, Brains, and Breakthroughs, a new educational campaign designed to raise public awareness and understanding of neurodevelopmental disorders through a series of accessible, family-informed video resources.
Study reveals blood stem cells can ‘remember’ inflammation
27 May 2026
Researchers have discovered that some human blood stem cells retain a lasting “memory” of inflammation, a finding that could help explain links between ageing, chronic disease, and blood cancers
12 Oxford scientists elected Fellows of the Royal Society
27 May 2026
Twelve renowned Oxford researchers have been elected Fellows of the Royal Society, the UK’s national academy of sciences, in recognition of their exceptional contributions to advancing scientific knowledge.
The Infectious Diseases Data Observatory awarded CoreTrustSeal certification
27 May 2026
The Infectious Diseases Data Observatory (IDDO) has been awarded the CoreTrustSeal, an internationally recognised certification for trustworthy data repositories.
Clinical trial of ketogenic therapy for early psychosis funded by Baszucki Group
26 May 2026
The University Oxford has received £1.17m of funding from Baszucki Group to assess the feasibility, safety, and efficacy of a ketogenic diet for patients at clinical high risk of psychosis (CHR-P).
Oxford researchers develop wearable ultrasound patch for continuous pregnancy monitoring
26 May 2026
New technology could help identify fetal complications earlier in high-risk pregnancies. Researchers at the University of Oxford and collaborators have helped develop a wearable ultrasound patch capable of continuously monitoring fetal wellbeing during pregnancy, offering a potential new approach to identifying complications earlier in high-risk pregnancies.
Expert comment: landmark plans to accelerate rare disease treatments in the UK are a welcome development
26 May 2026
Matthew Wood, Professor of Neuroscience in the Department of Paediatrics at the University of Oxford and Director & Chief Scientific Officer of the Oxford-Harrington Rare Disease Centre, comments on new government plans to bring treatments for rare diseases a step closer.
Opioid addiction linked to increased risk of dementia
22 May 2026
Major study finds opioid addiction raises dementia risk by 56% compared with non‑users.
Academy of Medical Sciences elects five Oxford researchers as new Fellows
22 May 2026
The Academy of Medical Sciences has elected five University of Oxford biomedical and health scientists to its fellowship in 2026.
Wearable GPS data expands understanding of schistosomiasis transmission
22 May 2026
Proximity to unsafe water strongly predicts schistosomiasis exposure, explaining sharp differences in infection and re‑infection across communities.
